Overview
Related Diseases & Conditions
- Merkel cell carcinoma
Summary
Merkel cell carcinoma is a rare, aggressive cutaneous neuroendocrine neoplasm that primarily affects white adults. Incidence increases with age and is highest among those >85 years of age.[5] Two distinct etiologies are recognized: exposure to UV radiation and oncogenic transformation by Merkel cell polyomavirus. Key risk factors are advancing age, immunosuppression, and light skin type. Diagnosis is confirmed with skin biopsy and histopathologic evaluation including immunohistochemistry. Occult metastasis is common, and sentinel lymph node biopsy and imaging are important tools for staging the disease. The tumor typically presents as an asymptomatic, rapidly growing, pink-to-violaceous or skin-colored dermal or subcutaneous nodule.[6] Summary
The most prevalent malignancy of the skin in fair-skinned adults in the world.[7] [8] It typically presents as pearly papules and/or firm plaques; nonhealing scabs; small crusts and nonhealing wounds; plaques, nodules, and tumors with rolled borders; and/or papules with associated telangiectasias.[9] [10]Image Strong risk factors include UV radiation via frequent sun exposure, x-ray exposure, arsenic exposure, xeroderma pigmentosum, nevoid basal cell carcinoma (Gorlin-Goltz syndrome), and history of transplantation. Metastases and advanced lesions are uncommon. Diagnosis is histologic.Summary
SCC is the proliferation of atypical, transformed keratinocytes in the skin with malignant behavior. Ranges from in situ tumors (Bowen disease) to invasive tumors and metastatic disease. Second most common nonmelanoma skin cancer worldwide, secondary to basal cell carcinoma.[8] Patients commonly present with a new or englarging lesion that they are concerned about, which may be tender or itchy, or a nonhealing wound originally caused by some trauma. In situ tumors are typically thin, flesh-colored to erythematous, scaly or hemorrhagic plaques, while invasive SCC may present as an exophytic tumor or ulcer.Image Tumors may be friable and bleed easily and are located mostly on sun-exposed areas of skin, such as the head and neck (84%) and extensor upper extremities (13%).[11] Cumulative UV exposure and immunosuppression are major risk factors. Presumptive diagnosis of SCC of the skin is usually based on a thorough history and clinical findings; however, skin biopsy confirms the diagnosis.[12]Summary
A malignant tumor arising from pigment-producing melanocytes found in the skin, eye, and central nervous system. Several variants exist. Clinical features of lesion asymmetry, border irregularity, color variability, diameter >6 mm, and evolution over time should raise suspicion for melanoma and prompt further assessment with dermoscopy.[13]Image Lesions are often on sun-exposed anatomic locations and more often in people with Fitzpatrick type I (white) skin. Lesions are more common on the trunk in men and on the legs and feet in women.[14] Early melanoma may be asymptomatic. History regarding a new or changing pigmented lesion should be obtained.Summary
A low-grade lymphovascular neoplasm associated with human herpesvirus-8 (HHV-8, also known as Kaposi sarcoma-associated herpesvirus [KSHV]) infection.[15] Lesions frequently involve mucocutaneous sites, but may become more extensive to involve the lymph nodes and visceral organs. Skin lesions evolve from an early patch, to a plaque, and later to ulcerating tumor nodules.Image There are four main subtypes: classic (sporadic); endemic (observed in sub-Saharan Africa); HIV-associated (formerly known as epidemic or AIDS-related); iatrogenic (transplant-related). Diagnosis is confirmed by biopsy and histopathology.[16]Summary
Heterogeneous group of uncommon disorders characterized by clonal accumulation of T lymphocytes primarily or exclusively in the skin. The incidence of cutaneous T-cell lymphomas has been reported as <10 per 100,000 population globally.[17] While the etiology remains unclear, theories include causative genomic alterations and infectious agents. Mycosis fungoides and its leukemic variant, Sézary syndrome, are the most common subtypes.[18] Establishing a diagnosis is often difficult, as the disease can manifest in a number of different ways, including flat patches, raised plaques, large tumors, and/or marked erythroderma (intense and widespread reddening of the skin).Image Diagnosis is based on clinical findings, skin biopsy (specimens should be sent for histology, immunophenotyping, and molecular studies), and laboratory blood tests, and usually requires specialist expertise.[19][20]Summary
Chronic keratotic lesions on adult skin that has been chronically exposed to UV rays. Lesions are skin-colored, yellowish, or erythematous, ill-defined, irregularly shaped, small, scaly macules or plaques localized in sun-exposed areas of the body (e.g., forehead, lower lip, dorsum of the hands and forearms, bald areas of the scalp, and ears).Image Typically, they occur in men age >40 years with light-colored skin and a history of chronic sun exposure. Actinic keratosis has the potential to progress into an invasive SCC. The risk of progression to SCC has been calculated to be between 0.025% and 16% per year.[21] [22] Although diagnosed clinically, a biopsy may help to rule out SCC.Summary
Sunburn is an acute inflammatory reaction of the skin induced by overexposure to UV radiation. Skin findings include erythema and edema, with or without vesiculation, followed by desquamation. Key risk factors include Fitzpatrick skin type I-III, photo-sensitizing drug, intentional tanning, and lack of or improper use of sunscreen. Symptoms include pain and/or pruritus. Characteristic history and physical exam findings are usually sufficient to make the diagnosis of sunburn. Primary prevention via sun avoidance, physical protection, and the appropriate use of sunscreen is key to preventing the condition, as cellular damage caused by UV radiation is irreversible and may with time increase the risk of skin cancer.
Images
Nodular basal cell carcinoma on the cheek, on background of diffuse solar damage with marked solar elastosis
Squamous cell carcinoma on the ear with surrounding actinic damage
Superficial spreading malignant melanoma
Kaposi sarcoma cutaneous purple-brown plaque on the foot
Cutaneous T-cell lymphoma: extensive patch disease
Regular actinic keratosis
Citations
1. Garbe C, Forsea AM, Amaral T, et al. Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them. Eur J Cancer. 2024 Jun;204:114074.[Abstract][Full Text]
2. Smith H, Wernham A, Patel A. When to suspect a non-melanoma skin cancer. BMJ. 2020 Mar 11;368:m692.[Abstract]
3. Psaty EL, Scope A, Halpern AC, et al. Defining the patient at high risk for melanoma. Int J Dermatol. 2010 Apr;49(4):362-76.[Abstract][Full Text]
4. Becerril S, Corchado-Cobos R, García-Sancha N, et al. Viruses and skin cancer. Int J Mol Sci. 2021 May 20;22(10):5399.[Abstract][Full Text]
5. Paulson KG, Park SY, Vandeven NA, et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018 Mar;78(3):457-63.e2.[Abstract][Full Text]
6. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008 Mar;58(3):375-81.[Abstract][Full Text]
7. Trakatelli M, Morton C, Nagore E, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014 May-Jun;24(3):312-29.[Abstract]
8. Roky AH, Islam MM, Ahasan AMF, et al. Overview of skin cancer types and prevalence rates across continents. Cancer Pathog Ther. 2024 Aug 8;3(2):89-100.[Abstract][Full Text]
9. Lear W, Dahlke E, Murray CA. Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg. 2007 Jan-Feb;11(1):19-30.[Abstract]
10. Raasch BA, Buettner PG, Garbe C. Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol. 2006 Aug;155(2):401-7.[Abstract]
11. Rundel RD. Promotional effects of ultraviolet radiation on human basal and squamous cell carcinoma. Photochem Photobiol. 1983 Nov;38(5):569-75.[Abstract]
12. Combalia A, Carrera C. Squamous cell carcinoma: an update on diagnosis and treatment. Dermatol Pract Concept. 2020 Jul 29;10(3):e2020066.[Abstract][Full Text]
13. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004 Dec 8;292(22):2771-6.[Abstract]
14. Stanienda-Sokół K, Salwowska N, Sławińska M, et al. Primary locations of malignant melanoma lesions depending on patients' gender and age. Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3081-3086.[Abstract][Full Text]
15. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994 Dec 16;266(5192):1865-9.[Abstract]
16. Cesarman E, Damania B, Krown SE, et al. Kaposi sarcoma. Nat Rev Dis Primers. 2019 Jan 31;5(1):9.[Abstract][Full Text]
17. Dummer R, Vermeer MH, Scarisbrick JJ, et al. Cutaneous T cell lymphoma. Nat Rev Dis Primers. 2021 Aug 26;7(1):61.[Abstract]
18. Olsen EA, Whittaker S, Kim YH, et al. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011 May 16;29(18):2598-607.[Abstract][Full Text]
19. Willemze R, Hodak E, Zinzani PL, et al. Primary cutaneous lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 1;29(suppl 4):iv30-40.
20. Gilson D, Whittaker SJ, Child FJ, et al. British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018. Br J Dermatol. 2019 Mar;180(3):496-526.[Abstract][Full Text]
21. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988 Apr 9;1(8589):795-7.[Abstract]
22. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):23-4.[Abstract]